Substituted pyridinones

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S256000, C514S336000, C546S283400, C546S296000, C544S333000

Reexamination Certificate

active

07067540

ABSTRACT:
Disclosed are compounds Formula Iand pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and R5are defined herein. These compounds are useful for treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase and/or TNF activity. Pharmaceutical compositions containing the compounds, methods of preparing the compounds and methods of treatment using the compounds are also disclosed.

REFERENCES:
patent: 3644626 (1972-02-01), Witzel
patent: 3654291 (1972-04-01), Graham et al.
patent: 3715358 (1973-02-01), Dorn et al.
patent: 5032602 (1991-07-01), Fey et al.
patent: 5164506 (1992-11-01), Fey et al.
patent: 5242928 (1993-09-01), Mederski et al.
patent: 5254543 (1993-10-01), Hanko et al.
patent: 5308854 (1994-05-01), Hoffman, Jr. et al.
patent: 5356911 (1994-10-01), Müller-Gliemann et al.
patent: 5378720 (1995-01-01), Hlasta et al.
patent: 5407948 (1995-04-01), Fey et al.
patent: 5414003 (1995-05-01), Fey et al.
patent: 5466701 (1995-11-01), Hlasta et al.
patent: 5532276 (1996-07-01), Mederski et al.
patent: 5599823 (1997-02-01), Müller-Gliemann et al.
patent: 5744605 (1998-04-01), Curran et al.
patent: 6255330 (2001-07-01), Goldmann et al.
patent: 6265350 (2001-07-01), Schnatterer et al.
patent: 267 045 (1989-05-01), None
patent: 0 336 369 (1989-10-01), None
patent: 0 500 297 (1992-08-01), None
patent: 0 547 708 (1993-06-01), None
patent: 0 626 378 (1994-11-01), None
patent: 0 733 629 (1996-03-01), None
patent: 1 289 187 (1972-09-01), None
patent: 9-315008 (1997-12-01), None
patent: 2000128878 (2000-05-01), None
patent: WO 86/01815 (1986-03-01), None
patent: WO 94/22835 (1994-10-01), None
patent: WO 96/22021 (1996-07-01), None
patent: WO 96/41639 (1996-12-01), None
patent: WO 97/10712 (1997-03-01), None
patent: WO 97/30708 (1997-08-01), None
patent: WO 97/40024 (1997-10-01), None
patent: WO 98/14169 (1998-04-01), None
patent: WO 98/31670 (1998-07-01), None
patent: WO 98/42698 (1998-10-01), None
patent: WO 99/52893 (1999-10-01), None
patent: WO 00/24719 (2000-05-01), None
patent: WO 00/31063 (2000-06-01), None
patent: WO 00/39102 (2000-07-01), None
Bantick et al.,Bioorganic&Medicinal Chemistry Letters(1994) 4(1):121-126.
Bartroli, et al.,Revista Icidca, (1988) 12(3):44-49.
Castillo, et al.,Bulletin De La Societe Chimique De France(1982) 7(8):257-261.
Edstrom, et al.,Tetrahedron Letters(1994) 35(38):6985-6988.
Frutos, et al.,J. Comb. Chem. (2000) 2:639-6.
Heber, et al.,Synlett(1999) 11:1747-1748.
Ivanov et al.,Liebiegs Ann Recueil, (1997) 8:1777-1781.
Ivanov, et al.,Chemical Abrstracts(1998) Heterocyclic Compounds (One Hetero Atom) 128(20):243931.
Katagiri, et al.,J. of Chem. Soc. (1986) 7:1289-1296.
Kiang, et al.,J. of Chem. Soc. (1971) 15:2721-2726.
Peseke, et al.,Wiss Z Willheim-Univ Rostock Naturwiss Reihel, (1988) 37(8):46-53.
Database Accession No. 5069110 (BRN)—XP002243098.
Database Accession No. 5587856 (BRN)—XP002243099.
Database Accession No. 63470000 (BRN)—XP002243100.
Database Accession No. 255148 (BRN)—XP00243101.
International Search Report for PCT/US03/04634.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted pyridinones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted pyridinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyridinones will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3676094

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.